LIVER KINASE B1 AS AN ONCOGENIC DRIVER IN LIVER CANCER

被引：1
|
作者：
Garcia-Rodriguez, J. L. [1 ]
Zubiete-Franco, I. [1 ]
Fernandez-Ramos, D. [1 ]
Fernandez-Tussy, P. [1 ]
Barbier-Torres, L. [1 ]
Lopitz-Otsoa, F. [1 ]
Gutierrez-de Juan, V. [1 ]
Martin-Plagaro, C. [2 ]
Aspichueta, P. [2 ]
Boix, L. [3 ]
Bruix, J. [3 ]
Calvisi, D. F. [4 ]
Varela-Rey, M. [1 ]
Fraga, M. F. [5 ]
Beraza, N. [1 ]
Lu, S. C. [6 ]
Mato, J. M. [1 ]
Delgado, T. C. [1 ]
Martinez-Chantar, M. L. [1 ]
机构：
[1] CIC BioGUNE, Metabol, Derio, Spain
[2] Univ Basque Country, Dept Physiol, Leioa, Spain
[3] Inst Invest Biomed August Pi & Sunyer, Liver Canc Grp, Barcelona, Spain
[4] Univ Med Greifswald, Inst Pathol, Greifswald, Germany
[5] Univ Oviedo, IUOPA, Oviedo, Spain
[6] Keck Sch Med USC, USC Res Ctr Liver Dis, Los Angeles, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30476-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0260
引用
收藏
页码：S403 / S403
页数：1
相关论文
共 50 条
  • [21] Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis
    Liu, Zhaoyu
    Zhu, Huaiping
    Dai, Xiaoyan
    Wang, Cheng
    Ding, Ye
    Song, Ping
    Zou, Ming-Hui
    CIRCULATION RESEARCH, 2017, 121 (09) : 1047 - +
  • [22] Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma
    Tan, Xiaolong
    Liao, Zhibin
    Liang, Huifang
    Chen, Xiaoping
    Zhang, Bixiang
    Chu, Liang
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (05) : 1913 - 1926
  • [23] Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells
    Nishimura, Sadaaki
    Yashiro, Masakazu
    Sera, Tomohiro
    Yamamoto, Yurie
    Sugimoto, Atsushi
    Kushiyama, Shuhei
    Togano, Shingo
    Kuroda, Kenji
    Okuno, Tomohisa
    Ohira, Masaichi
    CANCER RESEARCH, 2020, 80 (16)
  • [24] Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells
    Nishimura, Sadaaki
    Yashiro, Masakazu
    Sera, Tomohiro
    Yamamoto, Yurie
    Kushitani, Yukako
    Sugimoto, Atsushi
    Kushiyama, Shuhei
    Togano, Shingo
    Kuroda, Kenji
    Okuno, Tomohisa
    Murakami, Yoshiki
    Ohira, Masaichi
    CARCINOGENESIS, 2020, 41 (11) : 1616 - 1623
  • [25] Clinical features of aflatoxin B1-exposed patients with liver cancer and the molecular mechanism of aflatoxin B1 on liver cancer cells
    Zhou, Rui
    Liu, Meizhen
    Liang, Xiaoliu
    Su, Min
    Li, Rong
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2019, 71
  • [26] Impact of liver kinase B1 on p53 and survivin and its correlation with prognosis in gastric cancer
    Li, Weiwei
    Luo, Shunxiang
    Ma, Guowei
    Wang, Lin
    ONCOTARGETS AND THERAPY, 2019, 12 : 1439 - 1445
  • [27] Liver kinase B1 enhances chemoresistance to gemcitabine in breast cancer MDA-MB-231 cells
    Xia, Chen
    Ye, Fugui
    Hu, Xin
    Li, Zhengdong
    Jiang, Beiqi
    Fu, Yun
    Cheng, Xiaolin
    Shao, Zhiming
    Zhuang, Zhigang
    ONCOLOGY LETTERS, 2014, 8 (05) : 2086 - 2092
  • [28] Liver kinase B1 suppresses growth of lung cancer cells through sonic hedgehog signaling pathway
    Song, Kuiyuan
    Zheng, Guanqun
    Zhao, Yue
    CELL BIOLOGY INTERNATIONAL, 2018, 42 (08) : 994 - 1005
  • [29] Cloning and prokaryotic expression of the chicken liver kinase B1 (LKB1) and its localization in liver, heart and hypothalamus
    Zhang, Kun
    Shi, Yan
    Xu, Puzhi
    Huang, Cheng
    Zhou, Changming
    Liu, Ping
    Hu, Ruiming
    Zhuang, Yu
    Li, Guyue
    Hu, Guoliang
    Guo, Xiaoquan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 169 : 513 - 520
  • [30] Liver kinase B1 (LKB1) staves off γδ T-cell-mediated autoimmune liver disease
    Wang, Yiwen
    Wu, Lan
    Van Kaer, Luc
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (06) : 641 - 642
12345